securities fraud

DNOW Inc. stock fell 19.1% following disappointing Q4 2025 results that missed expectations, triggering securities investigation and class action lawsuit.

Soleno Therapeutics faces class action lawsuit over alleged failure to disclose safety issues with drug DCCR, following 12-27% stock declines from August-September 2025 revelations.

Schall Law Firm seeks investors in $LU securities lawsuit, alleging Lufax made false statements and failed internal controls between April 2023 and January 2025.

Class action lawsuit filed against monday.com alleging securities fraud over false revenue statements and concealed growth deceleration during September 2025-February 2026 period.

Bronstein, Gewirtz & Grossman files class action against BellRing Brands alleging false sales statements tied to inventory buildup rather than genuine demand.

Class action lawsuit filed against $PLUG alleging false statements on DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to seek lead plaintiff status.

Class action lawsuit filed against Ultragenyx Pharmaceutical alleging false statements about setrusumab efficacy for Osteogenesis Imperfecta treatment based on flawed trial comparisons.

Class action lawsuit filed against AMC Entertainment over alleged securities violations related to APE preferred equity units. Investors claim material misstatements about distribution rights.

Alight Inc. faces class action lawsuit alleging executives misled investors about CEO leadership, capital returns, and financial targets from November 2024 to February 2026.

Class action lawsuit filed against Eos Energy Enterprises ($EOSE) alleging executives made false statements about production capacity, battery downtime, and quality issues from November 2025 to February 2026.

Class action filed against $TCOM alleging false statements about regulatory risks from monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Class action filed against $EOSE alleging materially false statements and non-disclosure of production delays, battery downtime, and quality control failures.

Class action filed against China Liberal Education Holdings over alleged January 2025 pump-and-dump scheme involving social media fraud, resulting in significant investor losses.

Rosen Law Firm filed class action against Lufax Holding alleging false statements and inadequate financial controls. Investors face critical lead plaintiff deadline.

Rosen Law Firm files class action against Alight Inc., alleging false statements on financial health and dividends. Investors urged to secure counsel before deadline.

SES AI faces securities investigation after stock plunged 36.8% following March 4 earnings, allegedly due to undisclosed $1.5M shipment delays.

Medical device company $ZYXI files Chapter 11 after Tricare suspension, fraud indictments of executives, and systematic overbilling scheme. Class action filed.

Barclays faces class action investigation after £600M exposure to collapsed UK mortgage lender emerges, triggering 6.3% stock decline.

CRMT shares plummeted 18.2% after reporting Q1 loss of 69 cents per share versus 15 cents prior year. Securities lawsuit investigation underway.

PayPal faces securities fraud lawsuit over alleged revenue misstatements; stock fell 20.3% after CEO replacement and missed earnings. Investors must file for lead plaintiff status by April 20, 2026.